Moreover,studies targeting the tumor therapy target EGFR showed that kanamycinsignificantly enhanced the silencing effect of LNPs/siEGFR on EGFRmRNA and protein, suggesting its potential application in cancer genetherapy. Here, EGFR is linked to cancer.